244 related articles for article (PubMed ID: 14668702)
1. The management of the diabetic patient with prior cardiovascular events.
Fonarow GC
Rev Cardiovasc Med; 2003; 4 Suppl 6():S38-49. PubMed ID: 14668702
[TBL] [Abstract][Full Text] [Related]
2. An approach to heart failure and diabetes mellitus.
Fonarow GC
Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
[TBL] [Abstract][Full Text] [Related]
3. Managing the patient with diabetes mellitus and heart failure: issues and considerations.
Fonarow GC
Am J Med; 2004 Mar; 116 Suppl 5A():76S-88S. PubMed ID: 15019865
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes mellitus and heart failure.
Choy CK; Rodgers JE; Nappi JM; Haines ST
Pharmacotherapy; 2008 Feb; 28(2):170-92. PubMed ID: 18225964
[TBL] [Abstract][Full Text] [Related]
5. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
Dulin BR; Krum H
Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
[TBL] [Abstract][Full Text] [Related]
6. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
7. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M; Lamas GA
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
9. Heart failure in diabetic patients: utility of beta-blockade.
Kirpichnikov D; McFarlane SI; Sowers JR
J Card Fail; 2003 Aug; 9(4):333-44. PubMed ID: 13680555
[TBL] [Abstract][Full Text] [Related]
10. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
14. Diabetes, hypertension, and renal insufficiency in post-myocardial infarction cardiovascular risk.
Abraham WT
Rev Cardiovasc Med; 2003; 4 Suppl 3():S30-6. PubMed ID: 14564232
[TBL] [Abstract][Full Text] [Related]
15. Approach to the management of diabetic patients with heart failure: role of thiazolidinediones.
Fonarow GC
Am Heart J; 2004 Oct; 148(4):551-8. PubMed ID: 15459582
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of diabetic patients with ischaemic heart disease].
Hildebrandt PR; Snorgaard O; Melchior TM; Seibaek MB; Torp-Pedersen CT
Ugeskr Laeger; 2000 Jul; 162(31):4125-8. PubMed ID: 10962911
[TBL] [Abstract][Full Text] [Related]
17. [Interaction between congestive heart failure and diabetes mellitus: critical review of the literature].
Ferrua S; Bobbio M; Grassi G; Trevi G
Ital Heart J Suppl; 2001 Nov; 2(11):1192-200. PubMed ID: 11775411
[TBL] [Abstract][Full Text] [Related]
18. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
19. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment and prevention of heart failure in the diabetic patient.
Nesto RW
Rev Cardiovasc Med; 2004; 5(1):1-8. PubMed ID: 15029109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
